US EditionThe New Stakeholder Economics of Part D After the IRA
Summary by avalerehealth.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The New Stakeholder Economics of Part D After the IRA
On January 1, 2025, the Inflation Reduction Act (IRA)’s Medicare Part D redesign provisions went into effect for all Part D drugs. These provisions lower the beneficiary out-of-pocket (OOP) cap and increase plan and manufacturer liability, particularly in the catastrophic phase of coverage. Additionally, starting in 2026, select drugs will also be subject to Medicare drug price negotiation, further impacting market dynamics. Avalere Health exami…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
